Td Waterhouse Canada Inc. Phase Bio Pharmaceuticals Inc Transaction History

Td Waterhouse Canada Inc.

  • $14.8 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Nov 13, 2023
SELL
$0.0 - $0.12 $0 - $102
-850 Closed
0 $0
Q4 2021

Nov 13, 2023
BUY
$1.9 - $4.05 $1,615 - $3,442
850 New
850 $2.76 Million

About PhaseBio Pharmaceuticals Inc

PHAS Quotes by TradingView
  • Ticker PHAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,858,100
  • Description
  • PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or li...
More about PHAS
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email